Website & contact details
- Group website
- The site of this company’s group or brand.
Zentiva Pharma UK Limited
- Incorporated
- 28 August 1987 (39 years)
- Previously known as
- Winthrop Pharmaceuticals UK Limited (until 5 July 2018)Sterwin Medicines Limited (until 30 December 2004)Sanofi-Synthelabo Limited (until 1 November 2000)Earlier: Sanofi Pharma Ltd, Openheath Limited
- Industry
- Wholesale of pharmaceutical goods (46460)
- Directors
- Siddharth BanerjeeSophie Quin
- Accounts type
- Full
- Region
- Greater London
- Address
- 12 New Fetter LaneLondonEC4A 1JP
Filing status
- Accounts due
- 30 September 2027
- Last accounts
- 31 December 2025
- Conf. stmt due
- 14 January 2027
- Last conf. stmt
- 31 December 2025
Charges
- Total
- 2
- Outstanding
- 2
- Part satisfied
- 0
- Satisfied
- 0
Officers 2 active
Officer details are public data from the Companies House register.
Banerjee, Siddharth
Director · Appointed 3 June 2026
Indian
Born June 1990 (36)
Quin, Sophie
Director · Appointed 9 August 2022
British
Born February 1980 (46)
Officer history (27 former)
3 June 2026
Appointed Banerjee, Siddharth as Director
31 May 2026
22 January 2023
Resigned Hart, Luke Ingmire as Director
9 August 2022
Appointed Quin, Sophie as Director
30 November 2020
Resigned Hill, Jane as Director
9 September 2020
2 September 2019
Resigned Khandelwal, Manish as Director
15 July 2019
Appointed Hart, Luke Ingmire as Director
1 February 2019
Appointed Hill, Jane as Director
1 February 2019
Resigned Sell, Piret as Director
21 September 2018
Appointed Khandelwal, Manish as Director
21 September 2018
Appointed Sell, Piret as Director
21 September 2018
21 September 2018
1 January 2017
30 September 2016
1 April 2016
1 April 2016
19 November 2014
25 July 2014
1 October 2010
1 September 2010
12 May 2010
12 May 2010
12 May 2010
13 February 2008
30 January 2008
16 November 2007
Resigned Dark, Blake Alexander Richard as Director
16 November 2007
16 November 2007
31 December 2006
Resigned Jacob, Etienne Marie Charles Robert as Director
28 February 2005
Resigned King, Eric as Director
28 February 2005
Appointed Dark, Blake Alexander Richard as Director
8 November 2004
8 November 2004
8 November 2004
Appointed Jacob, Etienne Marie Charles Robert as Director
1 April 2003
1 April 2003
31 October 2002
Resigned Thiberge, Olivier Alain as Director
2 January 2001
2 January 2001
Appointed King, Eric as Director
2 January 2001
2 January 2001
Appointed Thiberge, Olivier Alain as Director
2 January 2000
2 January 2000
24 December 1998
24 December 1998
30 June 1996
30 June 1996
30 June 1996
30 June 1996
28 June 1994
Ownership 0 active
People and entities with significant control, from the Companies House PSC register
The company has declared that it has no person with significant control.
Former controllers (4)
8 April 2026
Ceased AI Sirona (Luxembourg ) Limited — Owns 75–100% of shares
1 September 2019
Ceased AI Sirona (Luxembourg ) Limited — Owns 75–100% of shares
30 September 2018
Ceased AI Sirona (Luxembourg) Acquisition S.A.R.L. — Owns 75–100% of shares
30 September 2018
Ceased Aventis Pharma Limited — Owns 75–100% of shares
Financials
Balance sheet as at 31 December 2025 · full accounts
- Net Assets
- £7,556,000
- Turnover
- £119,349,000
- Profit Before Tax
- £753,000
- Employees
- 51
- Debt Ratio
- 92%
- Current Ratio
- 1.8x
- Profit Margin
- 1%
- Return on Equity
- -10%
Balance sheet detail
| 2025 | |
|---|---|
| Fixed Assets | £7,824,000 |
| Current Assets | £83,967,000 |
| Creditors (< 1 year) | £46,574,000 |
| Creditors (> 1 year) | £35,609,000 |
| Net Current Assets | £37,393,000 |
| Net Assets | £7,556,000 |
| Shareholder Funds | £7,556,000 |
| Turnover | £119,349,000 |
| Cost of Sales | £101,527,000 |
| Gross Profit | £17,822,000 |
| Admin Expenses | £12,258,000 |
| Staff Costs | £7,224,000 |
| Operating Profit | £2,801,000 |
| Profit Before Tax | £753,000 |
| Tax | £1,544,000 |
| Profit for Period | (£791,000) |
Filings 208
| Date | Description | Made Up To | Pages | |
|---|---|---|---|---|
| 19 June 2026 | Full accounts | 31 December 2025 | ||
| 5 June 2026 | Appointment of a director | |||
| 1 June 2026 | Termination of appointment of a director | |||
| 22 May 2026 | Cessation of a person with significant control | |||
| 22 May 2026 | Notification of a person with significant control statement |
Some other companies at this address
Other companies in this industry
Bourne End
Bicester
Redditch
Chessington
London
London
By trade and location
Explore the largest companies
Need accounts figures, ownership or websites for thousands of companies? Bulk data & API →